Rule 8 Alltracel Pharmaceutic

RNS Number:6586O
J & E Davy
25 February 2008

                                                                FORM 8.1


                              IRISH TAKEOVER PANEL


 Lodge with the Irish Stock Exchange (Company Announcements Office) (which will
                                 publicise) and

the Panel. Use separate form for each class of securities in which dealings have
                                   been made.


                                Date of Disclosure:   25th February 2008


DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(I) and 8.3 OF THE IRISH TAKEOVER PANEL ACT
                          1997, (TAKEOVER) RULES, 1997


Date of Dealing:          22nd February 2008

Dealing in                Alltracel Pharmaceuticals


(1)  Class of Securities (e.g. ordinary shares)       Ordinary Eur 0.125

(2)

Amount bought                  Amount sold                     Price per unit
36,402                                                         GBP 0.125
     
(3)  Resultant total of the same class owned or controlled (and
percentage of class)

                                564,532                 (0.395%)

(4)  Party making disclosure      J&E Davy


(5)  EITHER (a)  Name of purchaser/vendor        J&E Davy

     OR     (b)  If dealing for discretionary client(s), name of fund management
                 Organisation

                 N/A
     
(6)  Reason for disclosure

             (a) (I)           offeror or associate of offeror          NO
                 (II)          offeree or associate of offeree          YES

                Specify which category or categories of associate ((a) to (l)

                page 3/4)

                If category (l) explain

                    
             (b)    Rule 8.3 (i.e. disclosure because of ownership or control of 
                    1% or more of the class of relevant securities dealt in)  NO



Signed, for and on behalf of the party named in (4) above
___________________________

(Also print name of signatory)                  Mark Smyth

Telephone and extension number                  01-6149063



This announcement has been issued through the Companies Announcement Service of
                           The Irish Stock Exchange.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
ISEEAFASADDPEFE

Alltracel Pharmaceuticals (LSE:AP.)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024